Boxer Asset Management Inc., 10% Owner at Esperion Therapeutics, Inc. (ESPR), sold 120,000 shares at $54.65 ($6.8M) on 2018-11-02, disclosed to the SEC on 2018-11-05.
Open-market sale of $6.8M ESPR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.65 | 2,500 | $137K | 2.0% |
| 2 | $55.25 | 37,500 | $2.1M | 30.4% |
| 3 | $55.21 | 26,500 | $1.5M | 21.4% |
| 4 | $56.19 | 6,500 | $365K | 5.4% |
| 5 | $57.38 | 2,000 | $115K | 1.7% |
| 6 | $58.82 | 6,390 |
| $376K |
| 5.5% |
| 7 | $58.82 | 6,390 | $376K | 5.5% |
| 8 | $59.48 | 13,610 | $810K | 11.9% |
| 9 | $59.48 | 13,610 | $810K | 11.9% |
| 10 | $60.28 | 5,000 | $301K | 4.4% |
| Total | $56.86 avg | 120,000 | $6.8M | 100% |
| Filing → |
| RAIN | BUY | 2021-04-27 | $19.8M | — | Filing → |
| ODT | BUY | 2020-12-30 | $6.9M | — | Filing → |
| PMVP | BUY | 2020-09-29 | $17.1M | — | Filing → |